CONTINUING MEDICAL EDUCATION (CME) QUESTIONS|
August 21, 2025
Allo-HCT in Hodgkin lymphoma after CPI Free
CME
Blood (2025) 146 (8): 1030.
Connected Content
A related article has been published:
Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis
Citation
Allo-HCT in Hodgkin lymphoma after CPI. Blood 2025; 146 (8): 1030. doi: https://doi.org/10.1182/blood.2025030720
Download citation file: